Skip to main content

Market Overview

Mornings Movers for Feb. 28, 2014: CETV, OTVI, MELI, REGI, GALE Moving Higher, ELGX, DECK, MDVN, CGEN, ARNA Lowr

Share:

Moving up:

  • Central European Media Enterprises (NASDAQ: CETV) - up 20% - Reports Q4 EPS of $(0.72); Revenue of $237.90M.
  • OmniVision Technologies (NASDAQ: OTVI) - up 15% - Reports Q3 EPS of $0.69 vs $0.35 Est; Revenue of $352.0M vs $326.63M Est. Sees Q4 EPS $0.19-0.35 vs $0.22 Est; Sees Sales $275.0M-305.0M vs $284.40M Est.
  • MercadoLibre (NASDAQ: MELI) - up 12.5% - Reports Q4 EPS of $0.93 vs $0.78 Est; Revenue of $134.60M vs $132.88M Est. Upgraded from Sell to Buy with $130 price target by Stifel Nicolaus.
  • Renewable Energy Group (NASDAQ: REGI) - up 6% - Reports Q4 EPS of $0.80 vs $0.75 Est; Revenue of $391.0M vs $347.17M Est.
  • Galena Biopharma (NASDAQ: GALE) - up 6% - NeuVax Patent Acceptance in Australia.
  • Sohu.com (NASDAQ: SOHU) - up 5.5% - Marbridge reported that Sohu and Tencent are in talks to merge video businesses.
  • Celsion (NASDAQ: CLSN) - up 4.5% - Reports positive interim data from Phase 2 DIGNITY trial in breast cancer.
  • Salix Pharmaceuticals (NASDAQ: SLXP) - up 5% - Reports Q4 EPS of $1.06 vs $0.93 Est; Revenue of $257.60M vs $247.29M Est. Sees FY2014 EPS $6.46.
  • Splunk (NASDAQ: SPLK) - up 4.5% - Reports Q4 EPS of $0.03 vs $0.05 Est; Revenue of $99.90M vs $90.36M Est. Bank of America maintains Buy on Splunk Inc., raises price objective to $100.00.
  • 3D Systems (NASDAQ: DDD) - up 4% - Reports Q4 EPS of $0.19 vs $0.20 Est; Revenue of $154.80M vs $155.07M Est; Reaffirms Outlook.

Moving down:

  • Endologix (NASDAQ: ELGX) - down 24% - Reported Q4 GAAP Loss of $0.05/Share vs Loss of $0.02/Share Est., Sales $35.2M vs $36.9M Est.; Said Expecting FY14 Sales $146-152M vs $161.2M Est.
  • Deckers (NASDAQ: DECK) - down 12% - Reports Q4 EPS of $4.04 vs $3.77 Est. Sees Q1 EPS $(0.16) vs $0.10 Est.
  • Medivation (NASDAQ: MDVN) - down 10.5% - Reports Q4 EPS of $0.03 vs $(0.08) Est; Revenue of $96.60M vs $72.68M Est.
  • Compugen (NASDAQ: CGEN) - down 10.4 - Prices 6M Share Public Offering at $10.50 per Share.
  • Arena Pharmaceuticals (NASDAQ: ARNA) - down 7% - Reports Q4 EPS of $(0.11) vs $0.02 Est; Revenue of $6.52M, Up 236% YOY.
  • Pier 1 Imports (NYSE: PIR) - down 5.7% - Sees Q4 Sales $512M-$514M vs $541.65M Est. Cuts Q4 EPS View to $0.40-$0.41 vs $0.51 Est.
  • Halozyme Therapeutics (NASDAQ: HALO) - down 3.8% - Reports Q4 EPS of $(0.19) vs $(0.17) Est.
  • Northern Oil & Gas (AMEX: NOG) - down 3.7% - Reports Q4 EPS of $0.22 vs $0.27 Est; Revenue of $101.90M vs $98.45M Est.
  • Questcor (NASDAQ: QCOR) - down 3.2% - Citron Research reveals that the company's Achtar gel is at risk of being pulled by the FDA.
  • Enzymotec (NASDAQ: ENZY) - down 3% - Reports Q4 EPS of $0.15 vs $0.11 Est; Revenue of $18.50M vs $18.77M Est.
  • United Continental (NYSE: UAL) - down 2% - Expecting Q1 Capacity Lower Than View, Cites Weather, Sees PRASM Down 0.5-2.5%.
  • InterMune (NASDAQ: ITMN) - down 2% - Downgrades InterMune, Inc. to Neutral, Maintains $33.00 PT, Balanced Risk/Reward is Reflected in Price.
 

Related Articles (CETV + OTVI)

View Comments and Join the Discussion!

Posted-In: News Short Sellers Movers

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com